US Patent 7420037 Heat shock protein-based vaccines and immunotherapies
Patent 7420037 was granted and assigned to Antigenics on September, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Paul Slusarewicz0
Sunil Mehta0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+315 characters)
Article
Patent abstract
Hybrid antigens comprising an antigenic domain and improved heat shock protein binding domains are described which are useful for the induction of an immune response to the antigenic domain and thus can be used to treat infectious diseases and cancers that express an antigen of the antigenic domain.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07420037 Heat shock protein-based vaccines and immunotherapies US Patent 7420037 Heat shock protein-based vaccines and immunotherapies
Infobox
Patent Number
074200370
Patent Number
74200370
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074200370
Date of Patent
September 2, 2008
0Patent Application Number
107765210
Date Filed
February 12, 2004
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07420037 Heat shock protein-based vaccines and immunotherapies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07420037
Date of patent
September 2, 2008
Patent application number
10776521
Date Filed
February 12, 2004
Patent primary examiner
Find more entities like US Patent 7420037 Heat shock protein-based vaccines and immunotherapies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
